title: Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
authors: Department of Psychiatry (Psychosomatic Medicine) Kyoto First Red Cross Hospital Kyoto, Japan pandasportiva@yahoo.co.jp Health Management Doctor's Office (Mental Health), Salary, Personnel Health and Welfare Division, Kyoto Prefecture and Department of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan Department of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan.
authors: Yasuhide
authors: Y
authors: Nagoshi
authors: Toshiyuki
authors: T
authors: Tominaga
authors: Kenji
authors: K
authors: Fukui
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000068180:Aripiprazole; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D015363:Quinolones / Q000008:administration & dosage / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013001:Somatoform Disorders / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D000068180:Aripiprazole; D010879:Piperazines; D015363:Quinolones; D017367:Selective Serotonin Reuptake Inhibitors